Stordahl Capital Management, Inc. Amgen Inc Transaction History

Stordahl Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $182,408 - $217,215	-843 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $197,809 - $219,980	843 New	843 $214,000
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $153,628 - $203,753	-843 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $159,504 - $205,017	843 New	843 $203,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $253,760 - $286,043	-1,403 Closed	0 $0
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $28,294 - $33,066	-167 Reduced 10.64%	1,403 $239,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $265,000 - $296,086	1,570	1,570 $273,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Stordahl Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Stordahl Capital Management, Inc. with notifications on news.